56-06-4 - Search Results | AbMole BioScience

About 6 results found for searched term "56-06-4" (0.053 seconds)

Cat.No.	Name	Target
M5342	Toceranib	VEGFR/PDGFR
	su-11654; pha-291639
	Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
M10163	Baloxavir marboxil	Anti-infection
	S-033188; RG 6152
	Baloxavir marboxil is a novel cap-dependent endonuclease inhibitor for the treatment of influenza A and B virus infections.
M11376	2,4-Diamino-6-hydroxypyrimidine	NO Synthase
	DAHP
	2, 4-diamino-6-hydroxypyrimidine is a specific inhibitor of GTP cyclohydrolase I, a rate-limiting enzyme involved in de novo protein synthesis. 2, 4-diamino-6-hydroxypyrimidine can block the synthesis of Tetrahydrobiopterin (BH4) and inhibit the production of NO.
M24718	Rinucumab	VEGFR/PDGFR
	REGN 2176
	Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration.
M42464	306-O12B	Liposome
	306-O12B is an ionizable cationic lipid used for the generation of lipid nanoparticles (LNPs).
M53951	Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled	Fluorescent Dye
	Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled, one of three mammalian natriuretic peptides (NPs), has endocrine effects on fluid homeostasis and blood pressure.